Bridger Management, LLC
- SEC CIK
- 0001166309
- Latest filing
- Aug 17, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Mar 25, 2024. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 44
- +1 vs. Q2 2022
- Portfolio value
- $330.5M
- −$113.1M (−25.5%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UBERUber Technologies, Inc | Stock | 1,246,009 | $33.0M | 10.0% | +252,700+25.4% | Added | History |
| MSMorgan Stanley | Stock | 342,214 | $27.0M | 8.2% | 00.0% | Unchanged | History |
| GDDYGoDaddy Inc. | CL A | 364,353 | $25.8M | 7.8% | −81,600−18.3% | Reduced | History |
| CHTRCharter Communications, Inc. | CL A | 68,159 | $20.7M | 6.3% | 00.0% | Unchanged | History |
| ALCAlcon Inc | Stock | 269,892 | $15.7M | 4.8% | −43,223−13.8% | Reduced | History |
| IRTCiRhythm Holdings, Inc. | COM | 120,879 | $15.1M | 4.6% | +1,100+0.9% | Added | History |
| CZRCaesars Entertainment, Inc. | COM | 411,753 | $13.3M | 4.0% | 00.0% | Unchanged | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,500,000 | $12.1M | 3.7% | 00.0% | Unchanged | History |
| Post Holdings Partnering Cor737465203 | UNIT 99/99/9999 | 1,250,000 | $12.1M | 3.6% | 00.0% | Unchanged | – |
| VRTXVertex Pharmaceuticals Inc | Stock | 39,772 | $11.5M | 3.5% | −33,300−45.6% | Reduced | History |
| HUMHumana Inc | Stock | 21,000 | $10.2M | 3.1% | −14,000−40.0% | Reduced | History |
| Avanti Acquisition CorpG0682V117 | UNIT 99/99/9999 | 1,000,000 | $10.0M | 3.0% | 00.0% | Unchanged | – |
| WRACWilliams Rowland Acquisition Corp. | COM | 950,000 | $9.58M | 2.9% | 00.0% | Unchanged | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 916,314 | $9.49M | 2.9% | −39,700−4.2% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 156,400 | $8.58M | 2.6% | −220,200−58.5% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 100,400 | $8.51M | 2.6% | −107,400−51.7% | Reduced | History |
| AIRSAirsculpt Technologies, Inc. | COM | 1,298,141 | $8.35M | 2.5% | −336,800−20.6% | Reduced | History |
| POSTPost Holdings, Inc. | COM | 100,298 | $8.21M | 2.5% | 00.0% | Unchanged | History |
| VRSNVerisign Inc | COM | 46,953 | $8.16M | 2.5% | −46,800−49.9% | Reduced | History |
| RCMR1 RCM Inc. | COM | 374,800 | $6.95M | 2.1% | +188,800+101.5% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 28,600 | $6.43M | 1.9% | +28,600 | New | History |
| SKINSkinHealth Systems Inc. | COM CL A | 446,607 | $5.26M | 1.6% | −648,103−59.2% | Reduced | History |
| SOCSable Offshore Corp. | COM CL A | 500,000 | $4.92M | 1.5% | 00.0% | Unchanged | History |
| MDUMdu Resources Group Inc | Stock | 175,500 | $4.80M | 1.5% | +175,500 | New | History |
| DCBODocebo Inc. | COM | 150,300 | $4.08M | 1.2% | 00.0% | Unchanged | History |
| BRBRBellring Brands, Inc. | Stock | 187,122 | $3.86M | 1.2% | 00.0% | Unchanged | History |
| BPMCBlueprint Medicines Corp | COM | 53,300 | $3.51M | 1.1% | +53,300 | New | History |
| STAAStaar Surgical Co | COM PAR $0.01 | 46,536 | $3.28M | 1.0% | +46,536 | New | History |
| RXSTRxSight, Inc. | COM | 221,732 | $2.66M | 0.8% | −109,700−33.1% | Reduced | History |
| CNCCentene Corp | Stock | 28,263 | $2.20M | 0.7% | −290,037−91.1% | Reduced | History |
| QTRXQuanterix Corp | COM | 198,600 | $2.19M | 0.7% | +53,916+37.3% | Added | History |
| Abcam PLC000380204 | ADS | 142,350 | $2.13M | 0.6% | 00.0% | Unchanged | – |
| XENEXenon Pharmaceuticals Inc. | COM | 45,235 | $1.63M | 0.5% | −32,165−41.6% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 47,703 | $1.63M | 0.5% | +3,303+7.4% | Added | History |
| SRZNSurrozen, Inc. | COM | 700,001 | $1.41M | 0.4% | 00.0% | Unchanged | History |
| LIVNLivaNova PLC | SHS | 26,790 | $1.36M | 0.4% | −29,100−52.1% | Reduced | History |
| MLCOMelco Resorts & Entertainment LTD | ADR | 200,000 | $1.33M | 0.4% | +200,000 | New | History |
| TOSTToast, Inc. | Stock | 52,692 | $881.0K | 0.3% | +52,692 | New | History |
| NAUTNautilus Biotechnology, Inc. | COM | 413,700 | $877.0K | 0.3% | +124,700+43.1% | Added | History |
| DMTKDermTech, Inc. | COM | 208,600 | $826.0K | 0.2% | −142,200−40.5% | Reduced | History |
| Advisorshares Tr00768Y453 | PURE US CANN ETF | 55,958 | $499.0K | 0.2% | −158,142−73.9% | Reduced | – |
| NEXINexImmune, Inc. | COM | 400,000 | $222.0K | 0.1% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 699,999 | $129.0K | <0.1% | +233,333+50.0% | Added | – |
| Williams Rowland Acquisition Corp.96951B110 | *W EXP 12/11/202 | 475,000 | $28.0K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q2 2022 (5)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| CLVTClarivate PLC | ORD SHS | 1,641,319 | $22.7M | 5.1% | History |
| PODDInsulet Corp | Stock | 41,000 | $8.94M | 2.0% | History |
| IMGNImmunoGen, Inc. | COM | 278,000 | $1.25M | 0.3% | History |
| VRDNViridian Therapeutics, Inc. | COM | 66,300 | $767.0K | 0.2% | History |
| TECHBIO-TECHNE Corp | COM | 1,444 | $501.0K | 0.1% | History |